Changjiang Pharmaceutical Group Past Earnings Performance
Past criteria checks 0/6
Changjiang Pharmaceutical Group's earnings have been declining at an average annual rate of -2.2%, while the Auto Components industry saw earnings growing at 8.2% annually. Revenues have been growing at an average rate of 10.1% per year.
Key information
-2.2%
Earnings growth rate
-2.1%
EPS growth rate
| Auto Components Industry Growth | 3.8% |
| Revenue growth rate | 10.1% |
| Return on equity | -80.9% |
| Net Margin | -56.3% |
| Last Earnings Update | 31 Mar 2024 |
Revenue & Expenses BreakdownBeta
How Changjiang Pharmaceutical Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 1,120 | -630 | 106 | 7 |
| 31 Dec 23 | 1,198 | -606 | 108 | 8 |
| 30 Sep 23 | 1,215 | -167 | 247 | 12 |
| 30 Jun 23 | 1,099 | -7 | 196 | 11 |
| 31 Mar 23 | 1,207 | -61 | 188 | 20 |
| 31 Dec 22 | 1,615 | -23 | 220 | 26 |
| 30 Sep 22 | 1,966 | -20 | 223 | 33 |
| 30 Jun 22 | 2,056 | -75 | 261 | 39 |
| 31 Mar 22 | 2,122 | 4 | 259 | 37 |
| 01 Jan 22 | 2,362 | 49 | 248 | 39 |
| 30 Sep 21 | 2,388 | 121 | 213 | 41 |
| 30 Jun 21 | 2,143 | 117 | 178 | 43 |
| 31 Mar 21 | 1,874 | 90 | 166 | 46 |
| 31 Dec 20 | 1,215 | 25 | 141 | 43 |
| 30 Sep 20 | 784 | -696 | 188 | 46 |
| 30 Jun 20 | 636 | -723 | 183 | 47 |
| 31 Mar 20 | 591 | -700 | 163 | 44 |
| 31 Dec 19 | 725 | -670 | 176 | 48 |
| 30 Sep 19 | 763 | 22 | 136 | 37 |
| 30 Jun 19 | 897 | 81 | 134 | 36 |
| 31 Mar 19 | 988 | 115 | 141 | 34 |
| 31 Dec 18 | 881 | 102 | 127 | 33 |
| 30 Sep 18 | 947 | 123 | 140 | 32 |
| 30 Jun 18 | 898 | 103 | 114 | 52 |
| 31 Mar 18 | 829 | 80 | 113 | 44 |
| 31 Dec 17 | 744 | 70 | 109 | 34 |
| 30 Sep 17 | 564 | 53 | 83 | 29 |
| 30 Jun 17 | 409 | 35 | 89 | 0 |
| 31 Mar 17 | 241 | 5 | 80 | 0 |
| 31 Dec 16 | 235 | 4 | 77 | 0 |
| 30 Sep 16 | 214 | 6 | 70 | 0 |
| 30 Jun 16 | 194 | -1 | 73 | 0 |
| 31 Mar 16 | 195 | 4 | 62 | 0 |
| 31 Dec 15 | 191 | 5 | 60 | 0 |
| 30 Sep 15 | 214 | 11 | 64 | 0 |
| 30 Jun 15 | 231 | 21 | 52 | 0 |
| 31 Mar 15 | 244 | 26 | 54 | 0 |
| 31 Dec 14 | 243 | 29 | 50 | 0 |
| 30 Sep 14 | 254 | 35 | 47 | 0 |
| 30 Jun 14 | 248 | 34 | 49 | 0 |
| 31 Mar 14 | 254 | 34 | 50 | 0 |
| 31 Dec 13 | 255 | 35 | 50 | 0 |
Quality Earnings: 300391 is currently unprofitable.
Growing Profit Margin: 300391 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300391 is unprofitable, and losses have increased over the past 5 years at a rate of 2.2% per year.
Accelerating Growth: Unable to compare 300391's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 300391 is unprofitable, making it difficult to compare its past year earnings growth to the Auto Components industry (28.1%).
Return on Equity
High ROE: 300391 has a negative Return on Equity (-80.93%), as it is currently unprofitable.